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Background: There are very few clinical reports that have compared the association between cigarette smoking
and microangiopathy in Asian patients with type 1 diabetes mellitus (T1DM). The objective of this study was to
assess the relationships between urinary protein concentrations and smoking and gender-based risk factors among
patients with T1DM.
Methods: A cross-sectional study of 259 patients with T1DM (men/women = 90/169; mean age, 50.7 years) who
visited our hospital for more than 1 year between October 2010 and April 2011 was conducted. Participants
completed a questionnaire about their smoking habits. Patient characteristics included gender, age, body mass
index, blood pressure, hemoglobin A1c, lipid parameters, and microangiopathy. Diabetic nephropathy (DN) was
categorized as normoalbuminuria (NA), microalbuminuria (MA), or overt albuminuria (OA) on the basis of the
following urinary albumin/creatinine ratio (ACR) levels: NA, ACR levels less than 30 mg/g creatinine (Cr); MA, ACR
levels between 30 and 299 mg/g Cr; and OA, ACR levels over 300 mg/g Cr.
Results: The percentages of current nonsmokers and current smokers with T1DM were 73.0% (n = 189) and 27.0%
(n = 70), respectively. In addition, the percentage of males was higher than that of females (52.2% versus 13.6%) in
the current smoking population. The percentage of DN was 61.8% (n = 160) in patients with NA, 21.6% (n = 56) in
patients with MA, and 16.6% (n = 43) in patients with OA. The percentage of males among OA patients was also
higher than that of females (24.4% versus 12.4%). However, current smoking status was associated with OA in
females with T1DM only [unadjusted odds ratio (OR), 4.13; 95% confidence interval (CI), 1.45–11.73, P< 0.01;
multivariate-adjusted OR, 5.41; 95% CI, 1.69–17.30, P< 0.01].
Conclusions: Based on our results in this cross-sectional study of Asian patients with T1DM, smoking might be a
risk factor for OA among female patients. Further research is needed of these gender-specific results.
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Type 1 diabetes mellitus (T1DM) is common in young
people [1-3]. Because high blood glucose levels begin at
a young age in T1DM, the early management of risk fac-
tors is important for preventing diabetic complications
in young patients with T1DM. Overt albuminuria (OA)
is a diabetic complication, and diabetic nephropathy* Correspondence: kokada@jichi.ac.jp
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reproduction in any medium, provided the or(DN) is a possible predictor of renal failure and mortality
in patients with T1DM [4,5]. The development of DN
has been shown to be associated with the duration of
diabetes, smoking, hemoglobin A1c (HbA1c) levels,
blood pressure levels, and dyslipidemia in T1DM
patients [6,7].
It has recently been reported that sex is an important
factor in the prevalence of smoking and cardiovascular
disease [8]. At present, only limited information is avail-
able regarding the association between DN and the
gender-based smoking status of T1DM patients [9]. TheLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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current smoking status is positively associated with the
progression of DN in male and female patients with
T1DM [9]. Because there have been very limited clinical
studies in the Asia-Pacific regions in particular, more
studies of the influence of gender on smoking habits in
DN patients are required. Therefore, the present study
aimed to examine risk factors, including current smok-
ing habits that can influence the gender-based presence
of OA in Japanese patients with T1DM.
Subjects and methods
A total of 259 patients with T1DM (men/women= 90/
169; mean age = 50.7 ± 16.8 years; duration of
diabetes = 17.0 ± 11.0 years) who visited our hospital for
more than 1 year between October 2010 and April 2011
were examined. The eligibility criteria were as follows:
age > 18 years, the absence of acute ketosis,
hypoglycemia, and pregnancy. T1DM was diagnosed
according to the Position Statement of the American
Diabetes Association [10]. T1DM was defined with the
following criteria: absolute insulin deficiency (urine C-
peptide levels < 20 μg/day, fasting serum C-peptide
levels < 0.5 μg/mL, or serum C-peptide levels < 1.0 μg/
mL after loading), susceptibility to ketosis, and require-
ment of insulin therapy within 1 year after diagnosis; all
patients in this study required insulin injections. Smok-
ing habits were confirmed by self-reports. Current
smoking status was considered as either smoking or not
smoking. The study protocol was approved by the Jichi
Medical University Ethical Committee.
The body mass index (BMI) and systolic/diastolic
blood pressure were measured in each patient. Blood
and urinary samples were collected at the outpatient
clinic in order to measure the levels of the following
parameters: HbA1c, total cholesterol (TC), triglyceride
(TG), and high-density lipoprotein cholesterol (HDL-C).
A high-performance liquid chromatography (HA8131;
Kyoto Daiichi Kagaku Co., Ltd., Tokyo, Japan) system
was used to measure HbA1c levels according to previous
Japanese standard substance and measurement methods.
National Glycohemoglobin Standardization Program-
equivalent values were obtained by using the following
equation: HbA1c =HbA1c (the Japan Diabetes Society) +
0.4 [11]. TC, TG, and HDL-C levels were measured by
enzymatic methods with an automatic analyzer (Hitachi
Co., Ltd., Tokyo, Japan).
Urinary albumin levels were measured with the tur-
bidimetric immunoassay method using a commercially
available kit (Auto Wako Albumin; Wako Pure Chemical
Industries, Ltd., Osaka, Japan), and urinary creatinine
levels were determined by an enzymatic method in order
to calculate the urinary albumin/creatinine ratio (ACR).
DN was classified as normoalbuminuria (NA),microalbuminuria (MA), or OA on the basis of the fol-
lowing ACR levels: NA, ACR levels less than 30 mg/g
creatinine (Cr); MA, ACR levels between 30 and
299 mg/g Cr; and OA, ACR levels over 300 mg/g Cr
[12]. Diabetic retinopathy and neuropathy were either
present or absent.
The data are presented as mean± standard deviation
(SD) by sex. Comparisons between the groups were
made with unpaired t-tests and Chi-square tests. Un-
adjusted, age-adjusted, and multivariate-adjusted logistic
regression analyses were performed in order to estimate
the factors associated with urinary albuminuria. The
multivariate-adjusted logistic regression analysis models
included age, BMI, systolic/diastolic blood pressure,
HbA1c levels, TC levels, TG levels, HDL-C levels, and
current smoking status at baseline as independent vari-
ables. Statistical significance was set at P values less than
0.05. All analyses were performed with the SPSS II soft-
ware package (IBM Corporation, Armonk, NY).Results
The clinical characteristics of the current smokers and
nonsmokers are shown by gender in Table 1. A total of
73% (n = 189) of the study population were nonsmokers,
while 27.0% (n = 70) reported themselves as current
smokers. Compared to males, females constituted a sig-
nificantly lower percentage of current smokers (52.2%
versus 13.6%, P < 0.01). In the nonsmoking group,
females had significantly higher HDL-C levels than
males, while a similar but nonsignificant difference in
HDL-C levels was seen in current smokers. In addition,
the percentage of nonsmoking patients with OA was sig-
nificantly higher in males than in females. For females,
the percentage of patients with OA was significantly
higher in current smokers than in nonsmokers.
The results of the unadjusted, age-adjusted, and
multivariate-adjusted logistic regression analyses for OA
are shown in Table 2. In males, systolic blood pressure
was independently, significantly, and positively asso-
ciated with OA. Diastolic blood pressure was signifi-
cantly and positively associated with OA in the
unadjusted and age-adjusted analyses, but it was no
longer significantly associated with OA in the
multivariate-adjusted logistic regression analysis. The
other variables, including current smoking status, were
not significantly associated with OA. In females, systolic
blood pressure was also independently, significantly, and
positively associated with OA. Current smoking status
was found to be significantly and positively associated
with OA in the unadjusted and age-adjusted analyses.
The multivariate-adjusted logistic regression analysis
revealed that current smoking status was independently,
significantly, and positively associated with OA (Odds
Table 1 Clinical characteristics
Current smoking Male Female
- + - + P1 P2 P3 P4
Total number (%) 43 (47.8) 47 (52.2) 146 (86.4) 23 (13.6) - - - -
Age (years) 53.2 ± 16.9 49.4 ± 12.6 51.3 ± 18.3 45.5 ± 12.6 0.54 0.24 0.23 0.15
Body mass index (kg/m2) 22.4 ± 2.8 22.7 ± 3.4 22.6 ± 3.9 21.8 ± 4.1 0.76 0.32 0.62 0.36
Systolic blood pressure (mmHg) 127.4 ± 24.0 132.3 ± 21.7 125.7 ± 18.8 123.4 ± 14.6 0.62 0.08 0.31 0.58
Diastolic blood pressure (mmHg) 70.8 ± 11.3 74.5 ± 14.6 71.2 ± 12.4 74.3 ± 10.2 0.83 0.94 0.18 0.26
HbA1c (%) 8.4 ± 2.0 8.3 ± 1.7 8.3 ± 2.0 8.7 ± 2.2 0.66 0.34 0.73 0.30
Total cholesterol (mg/dL) 189.7 ± 32.1 187.5 ± 41.4 199.1 ± 37.5 197.3 ± 35.9 0.14 0.34 0.78 0.84
Triglyceride (mg/dL) 96.9 ± 60.2 116.2 ± 81.9 94.7 ± 91.3 98.0 ± 58.5 0.88 0.34 0.21 0.87
HDL-cholesterol (mg/dL) 68.2 ± 18.1 67.2 ± 22.1 75.9 ± 19.1 74.3 ± 13.2 0.02 0.16 0.82 0.70
Complication, n (%)
Retinopathy 24 (55.8) 26 (55.3) 64 (43.8) 11 (47.8) 0.17 0.56 0.96 0.72
Neuropathy 28 (65.1) 28 (59.6) 86 (58.9) 15 (65.2) 0.46 0.65 0.59 0.57
Nephropathy
Normoalbuminuria 25 (58.1) 25 (53.2) 96 (65.8) 14 (60.9) 0.36 0.54 0.64 0.65
Microalbuminuria 9 (20.9) 9 (19.1) 36 (24.7) 2 (8.7) 0.61 0.26 0.83 0.09
Overt albuminuria 9 (20.9) 13 (27.7) 14 (9.6) 7 (30.4) 0.04 0.81 0.46 < 0.01
Data are presented as the number or mean ± S.D. HbA1c: hemoglobin A1c. HDL: high-density lipoprotein. P1: comparisons of respective variables between genders
in nonsmokers, P2: comparisons of respective variables between genders in current smokers, P3: comparisons of respective variables between nonsmokers and
current smokers in males, P4: comparisons of respective variables between nonsmokers and current smokers in females (using unpaired t-tests and Chi-square
tests).
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Discussion
In the present study, the female T1DM group had a
lower prevalence of OA than the male T1DM group.
Furthermore, current smoking status was significantlyTable 2 Logistic regression analysis for urinary protein (≥ 300
Male (n = 90)
Unadjusted Age-adjusted Multi-adjusted
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age (years) 1.00 (0.97–1.04) 0.81 - 1.00 (0.96–1.04) 0.8
BMI (kg/m2) 1.10 (0.94–1.28) 0.23 1.10 (0.94–1.28) 0.22 1.04 (0.84–1.23) 0.7
SBP (mmHg) 1.03 (1.01–1.06) < 0.01 1.03 (1.01–1.06) < 0.01 1.04 (1.00–1.08) 0.0
DBP (mmHg) 1.04 (1.00–1.08) 0.04 1.04 (1.00–1.08) 0.04 0.99 (0.94–1.05) 0.7
HbA1c (%) 0.99 (0.76–1.29) 0.95 0.99 (0.77–1.29) 0.96 1.05 (0.76–1.46) 0.7
TC (mg/dL) 1.01 (0.99–1.03) 0.09 1.01 (0.99–1.03) 0.09 1.01 (0.99–1.03) 0.2
Triglyceride
(mg/dL)
1.00 (0.99–1.01) 0.42 1.00 (0.99–1.01) 0.39 1.00 (0.99–1.01) 0.6
HDL-C
(mg/dL)
1.01 (0.99–1.03) 0.46 1.01 (0.99–1.03) 0.48 0.99 (0.95–1.02) 0.4
Current
smoking
1.44 (0.55–3.83) 0.46 1.48 (0.55–3.97) 0.44 1.15 (0.37–3.50) 0.8
OR: odds ratio. CI: confidence interval. BMI: body mass index. SBP: systolic blood pr
cholesterol. HDL-C: high-density lipoprotein-cholesterol. Multivariate-adjusted analy
current smoking status.associated with urinary OA in female T1DM patients,
while no factor was significantly associated with OA in
male T1DM patients. It is well known that the avoidance
of smoking has beneficial health effects in patients with
diabetes [13,14]. Furthermore, the proportion of smokers
in our country has been gradually decreasing as the
prevalence of smoking in patients with diabetes wasmg/g creatinine)
Female (n = 169)
Unadjusted Age-adjusted Multi-adjusted
OR (95% CI) P OR (95% CI) P OR (95% CI) P
5 0.99 (0.97–1.02) 0.48 - 0.96 (0.92–1.00) 0.07
2 0.97 (0.85–1.10) 0.59 0.97 (0.86–1.10) 0.62 0.96 (0.83–1.10) 0.52
3 1.03 (1.01–1.06) 0.02 1.05 (1.01–1.08) < 0.01 1.06 (1.02–1.11) 0.01
8 1.03 (0.99–1.07) 0.18 1.03 (0.99–1.07) 0.21 0.98 (0.93–1.03) 0.44
8 1.03 (0.83–1.27) 0.81 1.01 (0.82–1.26) 0.90 1.04 (0.77–1.39) 0.81
1 1.00 (0.98–1.01) 0.57 0.99 (0.98–1.01) 0.54 0.99 (0.97–1.01) 0.26
1 1.00 (0.99–1.01) 0.84 1.00 (0.99–1.01) 0.76 1.00 (0.99–1.01) 0.87
4 1.00 (0.97–1.02) 0.80 1.00 (0.97–1.02) 0.80 1.02 (0.98–1.06) 0.37
1 4.13 (1.45–11.73) < 0.01 4.00 (1.40–11.47) 0.01 5.41 (1.69–17.30) < 0.01
essure. DBP: diastolic blood pressure. HbA1c: hemoglobin A1c. TC: Total
sis models include age, BMI, SBP, DBP, HbA1c, TC, triglyceride, HDL-C, and
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Based on these results, we propose that female patients
with T1DM should cease smoking in order to prevent
DN.
Smoking increases the concentration of carboxyhemo-
globin, platelet aggregability, and the fibrinogen concen-
tration, all of which cause tissue hypoxia and contribute
to vascular damage [16,17], especially that caused by dia-
betes [18]. Glomerular hyperfiltration [19], the suppres-
sion of water excretion [20], and the effects of proximal
tubular damage [21] from smoking are the mediators of
DN progression.
In this study, we found a relatively stronger correlation
between smoking and DN in females than in males.
However, the underlying mechanisms for this remain
unclear. Smoking can decrease the atheroprotective
effects of estrogens [22,23]. Smoking appears to alter es-
tradiol metabolism, leading to the increased production
of inactive catechols [23]. This may be related to the in-
duction of estrogen-metabolizing cytochrome P450 iso-
enzymes [24]; furthermore, smoking lowers estrogen
activity [25,26]. The effects of estrogen dysfunction on
DN progression might be greater than the effects of a
lowered amount of estrogen (probably corresponding to
male patients). The oxidative milieu can result in proin-
flammatory effects of HDL [27,28]. In this study, HDL-C
levels in female patients were high relative to male
patients (particularly in nonsmokers); however, instead
of affecting the actual HDL-C levels, diabetic states
might make HDL dysfunctional. Functional studies to
verify these hypotheses are warranted.
Females were more likely to be assigned to a lower-
risk category than males, even though the former are at
an equivalent calculated risk [8]. Probably, a higher pro-
portion of females compared to males develop DN from
T1DM because of a lack of awareness and a systematic
delay in the diagnosis of complications. In Japan, a small
percentage of female individuals exhibit smoking habits
[15]; hence, this situation is less alarming for female
patients compared to male patients.
This study had a limitation related to the interpretation
of data that warrants mention. First, the sample size of the
groups may have been too small to produce definite con-
clusions. Moreover, it is necessary to consider that this
study was a cross-sectional study and was only conducted
at a single center. This study was performed in a local uni-
versity hospital, which might not be representative of the
entire T1DM population in Japan. One possibility is that
T1DM patients who had undergone kidney dialysis, espe-
cially males, would discontinue visiting our hospital.
Moreover, patients would visit our hospital when the com-
plications associated with diabetes had become severe and
progressive, as mentioned in a previous report [29].
Therefore, a multicenter study with a large number ofpatients is required. Second, because the dose of smoking
[5,30], the duration of smoking, and the type of cigarette
[31] were significantly associated with the progression of
nephropathy, we might have to investigate these factors in
detail. In addition, the self-reporting of smoking habits
can be questionable because of underreporting.
Conclusions
In conclusion, the present study suggested that current
smoking status can promote renal dysfunction in female
T1DM patients, and we may need to take into account
an individual’s smoking status in the management of
T1DM, especially in females.
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